GRAL GRAIL, Inc. Insider Trading

GRAL President sells 61.7K shares at $49.92; stock down -59.0% from 52-week high, company unprofitable with -$89.0M net income last fiscal year.

Joshua J. Ofman, President of GRAIL, sold 61,665 shares for $3,078,168.80 on April 8, 2026, reducing his holdings by 14.2% to 371,216 shares. The sale occurred at $49.92 per share, while the stock currently trades at $47.56, down 59.0% from its 52-week high of $116.06 and down 52.5% over the past 90 days. GRAL remains unprofitable with a net loss of $88,977,000.00 against revenue of $36,194,000.00 in the latest quarter, though the company posted annual revenue growth of 17.2%. At his same ticker, Ofman's prior five trades show mixed timing outcomes: two of his three measurable 90-day sales (December 2025 and October 2025) resulted in negative returns after sale, consistent with well-timed exits, but his most recent prior sales (March 2026) have shown limited downside follow-through to date. The current sale occurs during a period of significant stock weakness, warranting scrutiny of whether Ofman's conviction in the company's ability to reach profitability remains intact.

CFO Aaron Freidin sold 45,806 shares of GRAL at $49.92; stock now -59.0% from 52-week high.

Aaron Freidin, Chief Financial Officer of GRAIL Inc., executed a sale of 45,806 shares at $49.92 on 2026-04-08, reducing his holdings by 14.9% from 306.5K to 260.7K shares. The company is trading at $47.56, down 59.0% from its 52-week high of $116.06 and down 52.5% over the past 90 days. GRAL remains unprofitable with -$89.0M net income against $36.2M quarterly revenue, despite 17.2% annual revenue growth. His prior sell at GRAL on 2025-12-03 resulted in a 90-day decline of -46.8%, which was well-timed; his May 2025 GRAL sale showed a 90-day gain of +0.8%. Across his cross-ticker open-market trading history, his 2 prior sells averaged -23.0% over 90 days with a 50% well-timed rate. The April 2026 sale has declined 2.3% over the past 30 days from the transaction price.

CEO Robert Ragusa sold 123.5K GRAL shares at $49.92 (now $47.56); 90-day returns on 3 recent sells all negative

Robert Ragusa, Chief Executive Officer of GRAIL, sold 123.5K shares valued at $6.2M on 2026-04-08, reducing his holdings by 19.2% to 518.6K shares. The stock has since fallen from his sale price of $49.92 to a current $47.56, representing a 59.0% decline from the 52-week high of $116.06. Examining his prior activity at GRAL is instructive: three separate sales in December 2025 and March 2026 each generated negative 90-day returns (-44.6%, -45.8%, -45.2%), resulting in a 100% well-timed rate on measurable GRAL trades. The current sale follows this pattern of prior negative post-sale performance at this ticker. The company fundamentals remain challenging—GRAL reported $36.2M in quarterly revenue alongside a $-89.0M net loss and remains unprofitable on a full-year basis, with an atypical P/E of 1.61. This concentration of recent CEO sales aligned with deteriorating post-sale price action warrants careful scrutiny of company-specific headwinds.

GRAL President Ofman sold 17.0K shares for $852.8K amid -46.1% 30-day and -47.9% 90-day declines

Joshua J. Ofman, President of GRAIL, Inc., executed 2 separate sales totaling 17.0K shares for $852.8K on 2026-03-02 at a blended average price of $50.16, reducing his holdings by 3.7% to 436.5K shares. The stock has declined sharply: -46.1% over 30 days and -47.9% over 90 days from the transaction date, trading 54.5% below its 52-week high of $116.06. His prior sales at GRAL show a mixed timing record: 1 of 5 prior sells were well-timed at the 90-day mark, with the most recent sale on 2025-12-03 followed by a -47.2% 90-day decline. The company remains deeply unprofitable with a -$89.0M net loss on $36.2M quarterly revenue, despite 34.9% annual revenue growth. This sale occurs within the context of significant stock deterioration and a pattern of prior dispositions at this ticker, warranting attention to whether further shareholder dilution or operational headwinds may be emerging.

GRAL CEO Ragusa sells 37,504 shares for $1.9M; stock down 46.1% in 30 days, -54.5% from high.

CEO Robert P Ragusa executed 2 separate sales totaling 37,504 shares for $1,881,417.06 on 2026-03-02, reducing his holdings by 5.5% to 650,525 shares post-transaction. The sales occur against a backdrop of severe recent price deterioration: the stock has declined 46.1% over the prior 30 days and trades 54.5% below its 52-week high of $116.06. At the same ticker, Ragusa's 5 prior trades show a 80% pattern of well-timed sells at the 90-day mark (4 of 5 prior sales resulted in negative 90d returns, including three consecutive December 2025 sales with 90d declines ranging from -44.1% to -45.8%). The company context is unfavorable: it posted negative annual net income of $-89.0M against quarterly revenue of $36.2M, though annual revenue growth of +34.9% shows operational momentum. This filing documents a high-conviction reduction in insider shareholding during a period of acute stock weakness and near the bottom of the recent range.

CFO Aaron Freidin sold 25,000 GRAL shares at $99.15 on 2025-12-03; stock up 19.3% in 30d but down 9.4% from 52-week high.

Freidin sold 25,000 shares (8.8% of his pre-transaction holdings) for $2,478,817.50 at a price 9.4% below the 52-week high. His cross-ticker track record shows 1 prior sell with a 0.00% well-timed rate, indicating prior sells were poorly timed—the stock rose after, not fell. At GRAL specifically, his single prior sell on 2025-05-02 showed a +0.8% 90-day return, meaning the stock also rose following that sale. Despite recent strong price momentum (stock up 19.3% over 30 days and 173.6% over 90 days), the company remains unprofitable with a net income of -$89.0M against $36.2M quarterly revenue, even as annual revenue growth reached 34.9%. The timing and frequency of this sale relative to the company's negative profitability warrant monitoring.

GRAL CEO sold 40,000 shares for $3.8M across 4 transactions on 2025-12-03; stock up 19.3% in 30 days, 173.6% in 90 days

Robert P. Ragusa, CEO of GRAIL Inc., executed 4 separate sales totaling 40,000 (40.0K shares) for $3,809,534.92 on 2025-12-03, reducing his holdings from 728,029 to 688,029 shares (a -5.5% reduction). The stock has appreciated substantially since the transaction date: +19.3% over 30 days and +173.6% over 90 days, both measured from current price of $100.98. His prior 2 sells at GRAL (2025-05-02 and 2024-10-15) were not well-timed at the 90-day mark: both were followed by positive returns (+13.2% and +12.8% at 30 days, but +0.8% and +32.4% at 90 days, respectively). Against a company backdrop of negative net income ($-89.0M) despite strong revenue growth (+34.9% annual), this sale represents a routine liquidation by the CEO that has not preceded a material decline in stock price.

GRAL President Joshua J. Ofman sold 13,000 shares at $100.00 on 2025-12-03; stock now at $100.98. 90-day momentum +173.6%.

Joshua J. Ofman, President of GRAIL Inc., executed a sale of 13,000 shares (13.0K shares) for $1,300,000.00 ($1.3M) at $100.00 per share, reducing his holdings from 381,818 shares (381.8K shares) to 368,818 shares (368.8K shares). The sale occurred as GRAL stock has surged +173.6% over 90 days and +19.3% over the past 30 days, trading near its 52-week high of $111.40. His cross-ticker track record shows 7 prior sales with a 90-day well-timed rate of 66.67%, but at GRAL specifically, only 1 of 1 measurable prior sales (the 2025-06-30 trade) was well-timed at the 90-day mark, with a 90-day outcome of -4.1%. The company remains unprofitable with a net income of $-89.0M against $36.2M in quarterly revenue, though it has posted +34.9% annual revenue growth. The insider retained 368.8K shares post-transaction, representing continued material exposure to the business.

Illumina sold 1,000,000 GRAL shares (22.2% of holdings) for $79.8M on 2025-11-17; retains 3.50M shares at $3.2B market cap.

Illumina, a major 10% shareholder in GRAL, executed a substantial sale of 1,000,000 shares representing 22.2% of its pre-transaction holdings for $79,850,000. The timing occurs amid rapid 90-day appreciation (+153.2%) and at a price ($79.85) approaching the 52-week high ($91.93), though GRAL remains an unprofitable company with net income of $-88,977,000 over its most recent full fiscal year. The sale maintains Illumina's continued 10% ownership position through its 3,502,126 remaining shares, signaling neither a complete exit nor a fundamental confidence loss, but rather a reduction in exposure during a period of significant valuation expansion. This partial liquidation warrants monitoring given GRAL's negative profitability, rapid revenue growth of 34.9% annually, and the recent steep share-price surge relative to operational fundamentals.

GRAL President Ofman sells 14,979 shares in 2 tranches (Oct 15-16) for $1.2M at $78.47 avg; stock now at $86.41 (+0% from 52-wk high, +122.8% in 30d)

Joshua J. Ofman, President of GRAIL Inc., executed 2 separate sales totaling 14,979 shares for $1,175,393.81 on 2025-10-15 and 2025-10-16, reducing his holdings by 3.8% to 381.8K shares. The sales occurred at a blended average price of $78.47, while the stock now trades at $86.41 (at its 52-week high) — a $7.94 gap suggesting the insider sold ahead of continued appreciation in a market that has rallied +122.8% over the past 30 days and +145.6% over 90 days. At the same ticker, Ofman's prior 3 measurable sales (2024-08-21, 2025-05-02, 2025-06-30) showed a 2-of-3 well-timed rate at the 90-day mark; this recent sale occurred during extraordinary momentum (+145.6% in 90 days), yet the current $86.41 price exceeds the transaction prices, meaning this sale has not yet preceded a decline. The company remains unprofitable (net income of $-114.0M in its latest full fiscal year) despite strong revenue growth of +34.9%, creating tension between momentum metrics and fundamental weakness that warrants monitoring.